Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 244
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05851027 | Evaluating the Efficacy and Safety of QL0911 in Chemotherapy- Induced Thrombocytopenia | ||
| NCT07151872 | Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract Cancer | ||
| NCT06644495 | Post-Market Surveillance Study of ALK-Positive Advanced NSCLC Participants Treated With Iruplinalkib | ||
| NCT07081256 | To Evaluate the Efficacy and Safety of QLM2010 for Prevention of Chemotherapy-induced Nausea and Vomiting After Highly Emetogenic Chemotherapy. | ||
| NCT06406205 | A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis | ||
| NCT05799820 | QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRC | ||
| NCT07358884 | First in Human Study of QLS5316 in Solid Tumors | ||
| NCT06254235 | Bioequivalence Study of Two Octreotide Microsphere Formulations in Healthy Volunteers | ||
| NCT07622836 | A Prospective, Multicenter, Phase II Clinical Study of Postoperative Chemotherapy Combined With QL1706 for High-risk Triple-negative Breast Cancer. | ||
| NCT07327697 | A Comparative Phase 1 Study to Evaluate the Pharmacokinetic and Safety of QL2302 vs. Tezspire® in Healthy Subjects | ||
| NCT06898060 | To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of Fracture | ||
| NCT06403735 | A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors | ||
| NCT05262413 | A Study of QL1706 Plus Lenvatinib in Subjects With Advanced Renal Cell Carcinoma(RCC) | ||
| NCT05649761 | A Phase I Study of QL1604 in Subjects With Advanced Solid Tumors | ||
| NCT06446388 | Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors | ||
| NCT05973149 | Trial of QLH12016 in Patients With Metastatic Castration Resistant Prostate Cancer | ||
| NCT06754644 | A Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLC | ||
| NCT06671548 | Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids | ||
| NCT07040228 | A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer | ||
| NCT06980909 | The Food Effect on Pharmacokinetics Study of QLC1101 in Healthy Subjects | ||
| NCT05461287 | Safety, Tolerability and Pharmacokinetics Study of QLS31904 in Patients With Advanced Solid Tumors | ||
| NCT07450378 | QLC7401 in Participants With Heterozygous Familial Hypercholesterolemia (HeFH) | ||
| NCT07489599 | A Study of QLH2405 in Healthy Participants and Participants With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease | ||
| NCT07152444 | A Phase I Trial of QLS1410 in Healthy Chinese Adults and Participants With Mild Essential Hypertension | ||
| NCT06749899 | QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma. | ||
| NCT03244085 | A Study to Investigate the Safety, Efficacy and Pharmacokinetic Profile of Multiple Doses of QL-007 in Chronic Hepatitis B Patients | ||
| NCT06880276 | Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis | ||
| NCT05801107 | Study to Investigate the Efficacy and Safety of WX-0593 in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients | ||
| NCT05621330 | Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune Thrombocytopenia | ||
| NCT04705519 | Nab-paclitaxel Combined with Bevacizumab in the Treatment of Metastatic Extrapulmonary Neuroendocrine Carcinoma | ||
| NCT07138885 | A Phase II, Single-Arm, Prospective Trial on the Efficacy and Safety of QL1706 Combination Regimen as Second-Line Therapy for Targeted-Immunotherapy-Resistant Hepatocellular Carcinoma | ||
| NCT05830045 | A Phase I Study of QLP2117 in Subjects With Advanced Solid Tumors | ||
| NCT03770624 | A Study to Investigate the Safety, Efficacy and PK of Multiple Doses of QL-007 in Chronic Hepatitis B Patients in CHINA | ||
| NCT06925659 | A Study of QLM2011 in Subjects With Advanced Solid Tumors | ||
| NCT01931943 | A Phase Ib Study of Selatinib Ditosilate Tablets in Patients With Advanced Breast Cancer | ||
| NCT07802821 | A Study Comparing QLC5508 in Combination With QL2107 Versus Tislelizumab Plus Platinum-based Chemotherapy in Participants Wih Treatment-naïve Extensive-Stage Small Cell Lung Cancer | ||
| NCT04486430 | Efficacy and Safety Study of Neu2000KWL for Acute Ischemic Stroke Patients Within 6 Hours of Onset | ||
| NCT05922436 | a Study Evaluating the Safety and Efficacy of Clevidipine for Patients Who With Hypertensive Emergency and Sub-emergency | ||
| NCT07550465 | Study of QLS1410 in the Treatment of Primary Aldosteronism. | ||
| NCT06371534 | A Study Comparing Pharmacokinetic and Safety of QL2109 and DARZALEX FASPRO® in Healthy Adults | ||
| NCT06173011 | A Study Comparing Pharmacokinetic and Safety of QL2107 and Keytruda® (Marketed in China and the United States) in Healthy Adults | ||
| NCT07444086 | QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia | ||
| NCT07829952 | Efficacy and Safety of Romiplostim N01 for Injection in Promoting Platelet Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation | ||
| NCT07462442 | Study of QLS5308 in Patients With Advanced Solid Tumors | ||
| NCT03104010 | A Non-inferiority Phase 2 Study to Evaluate the Safety and Efficacy of PEG-rhGH in the Treatment of AGHD | ||
| NCT07173595 | A Phase I Study of QLS2309 Injection in Patients With CD70+ Relapsed/Refractory Hematologic Malignancies | ||
| NCT07455006 | Safety and Efficacy Study of QL0911 to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients | ||
| NCT05976568 | A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma | ||
| NCT05801094 | A Phase I Study of QL1604 for Advanced Solid Tumors | ||
| NCT07331545 | Safety, Tolerability, PK, PD, and Immunogenicity of QL2401 in Healthy Chinese Adults |
